NDC 0019-0953

Conray

Iothalamate Meglumine

Conray is a Intravascular Injection in the Human Prescription Drug category. It is labeled and distributed by Liebel-flarsheim Company Llc. The primary component is Iothalamate Meglumine.

Product ID0019-0953_010a376a-cf48-4daa-9b83-a5b2264e3f3c
NDC0019-0953
Product TypeHuman Prescription Drug
Proprietary NameConray
Generic NameIothalamate Meglumine
Dosage FormInjection
Route of AdministrationINTRAVASCULAR
Marketing Start Date2003-10-14
Marketing CategoryNDA / NDA
Application NumberNDA013295
Labeler NameLiebel-Flarsheim Company LLC
Substance NameIOTHALAMATE MEGLUMINE
Active Ingredient Strength600 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0019-0953-05

25 VIAL, GLASS in 1 BOX (0019-0953-05) > 50 mL in 1 VIAL, GLASS
Marketing Start Date2003-10-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0019-0953-50 [00019095350]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14

NDC 0019-0953-03 [00019095303]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-10-14
Marketing End Date2019-10-31

NDC 0019-0953-23 [00019095323]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14

NDC 0019-0953-10 [00019095310]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-10-14

NDC 0019-0953-13 [00019095313]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14
Marketing End Date2019-10-31

NDC 0019-0953-11 [00019095311]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14
Marketing End Date2019-10-31

NDC 0019-0953-05 [00019095305]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14

NDC 0019-0953-09 [00019095309]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14
Marketing End Date2019-10-31

NDC 0019-0953-15 [00019095315]

Conray INJECTION
Marketing CategoryNDA
Application NumberNDA013295
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2003-10-14
Marketing End Date2019-10-31

Drug Details

Active Ingredients

IngredientStrength
IOTHALAMATE MEGLUMINE600 mg/mL

OpenFDA Data

SPL SET ID:1292abfc-496f-4df7-9a08-72072953e1f1
Manufacturer
UNII
UPC Code
  • 0300190953507
  • Pharmacological Class

    • Radiographic Contrast Agent [EPC]
    • X-Ray Contrast Activity [MoA]

    NDC Crossover Matching brand name "Conray" or generic name "Iothalamate Meglumine"

    NDCBrand NameGeneric Name
    0019-0953Conrayiothalamate meglumine
    0019-3183Conray 43iothalamate meglumine
    0019-0862Cysto-Conray IIIothalamate meglumine

    Trademark Results [Conray]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CONRAY
    CONRAY
    72128071 0737390 Live/Registered
    MALLINCKRODT CHEMICAL WORKS
    1961-09-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.